These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32691170)

  • 1. Gint4.T-Modified DNA Tetrahedrons Loaded with Doxorubicin Inhibits Glioma Cell Proliferation by Targeting PDGFRβ.
    Wang F; Zhou Y; Cheng S; Lou J; Zhang X; He Q; Huang N; Cheng Y
    Nanoscale Res Lett; 2020 Jul; 15(1):150. PubMed ID: 32691170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Assembled DNA Nanostructure as a Carrier for Targeted siRNA Delivery in Glioma Cells.
    Zhou Y; Yang Q; Wang F; Zhou Z; Xu J; Cheng S; Cheng Y
    Int J Nanomedicine; 2021; 16():1805-1817. PubMed ID: 33692623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier.
    Shi S; Fu W; Lin S; Tian T; Li S; Shao X; Zhang Y; Zhang T; Tang Z; Zhou Y; Lin Y; Cai X
    Nanomedicine; 2019 Oct; 21():102061. PubMed ID: 31344499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7-positive tumours.
    Liu M; Ma W; Li Q; Zhao D; Shao X; Huang Q; Hao L; Lin Y
    Cell Prolif; 2019 Jan; 52(1):e12511. PubMed ID: 30311693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.
    Camorani S; Esposito CL; Rienzo A; Catuogno S; Iaboni M; Condorelli G; de Franciscis V; Cerchia L
    Mol Ther; 2014 Apr; 22(4):828-41. PubMed ID: 24566984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahedral DNA Nanostructure-modified Gold Nanorod-based Anticancer Nanomaterials for Combined Photothermal Therapy and Chemotherapy.
    Wu H; Xu JS; Li YH; Wu XH; Hu W; Liu MD; Sun Q; Guo B
    Biomed Environ Sci; 2022 Dec; 35(12):1115-1125. PubMed ID: 36597291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
    Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro.
    Dai B; Hu Y; Duan J; Yang XD
    Oncotarget; 2016 Jun; 7(25):38257-38269. PubMed ID: 27203221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold nanorods/tetrahedral DNA composites for chemo-photothermal therapy.
    He Z; Wang Q; Zhang N; Yan J; Li L; Cao J; He B
    Regen Biomater; 2022; 9():rbac032. PubMed ID: 35668924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
    Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoferritin Nanocage for Brain Targeted Doxorubicin Delivery.
    Chen Z; Zhai M; Xie X; Zhang Y; Ma S; Li Z; Yu F; Zhao B; Zhang M; Yang Y; Mei X
    Mol Pharm; 2017 Sep; 14(9):3087-3097. PubMed ID: 28728419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Penetrating Peptide-Modified DNA Tetrahedron for Targeting Drug Delivery.
    Xia Z; Wang P; Liu X; Liu T; Yan Y; Yan J; Zhong J; Sun G; He D
    Biochemistry; 2016 Mar; 55(9):1326-31. PubMed ID: 26789283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
    Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
    Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
    Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
    J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
    Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
    Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q
    Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
    Cui Y; Xu Q; Chow PK; Wang D; Wang CH
    Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopep-2-conjugated poly(ethylene glycol)-
    Lu F; Pang Z; Zhao J; Jin K; Li H; Pang Q; Zhang L; Pang Z
    Int J Nanomedicine; 2017; 12():2117-2127. PubMed ID: 28356732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel synergetic targeting strategy for glioma therapy employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer.
    Han S; Zheng H; Lu Y; Sun Y; Huang A; Fei W; Shi X; Xu X; Li J; Li F
    J Drug Target; 2018 Jan; 26(1):86-94. PubMed ID: 28635335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.